Australian Manufacturing Facility Achieves ISO 13485
Filed with ASX · · 3 pages · English
Earlier from OncoSil Medical
- OSL Secures $5.6 million from Major Institutional Investors
- OncoSil Receives FDA Approval for Distal Cholangiocarcinoma
- OncoSil Medical Completes Manufacturing Validation
- OncoSil Medical Files for FDA Approval
- OncoSil Selected for Major European Pancreatic Cancer Study
Later from OncoSil Medical
All OncoSil Medical news releasesFollow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical